Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Prichek-M 1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Indoco Remedies Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Prichek-M 1 Tablet SR

Diabeticaid-Duo, a sustained-release tablet, is an antidiabetic medication combining two active components for adult type 2 diabetes management. It effectively regulates blood glucose. Diabeticaid-Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's part of a comprehensive plan encompassing a balanced diet, regular physical activity, and weight management as advised by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect; learn its symptoms (sweating, dizziness, headache, tremors) and management. Maintain regular mealtimes and carry a fast-acting glucose source (e.g., sugary snacks, juice). Alcohol increases hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Disclose any history of heart disease to your doctor prior to use; pregnancy or breastfeeding necessitates medical consultation. Regular blood glucose checks are essential, along with potential blood tests to monitor blood cell counts and liver function.

Uses of Prichek-M 1 Tablet SR

Managing type 2 diabetes

Major Benefits of Prichek-M 1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take Prichek-M 1 Tablet SR with a meal.

Common Side effects of Prichek-M 1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Prichek-M 1 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take one Prichek-M SR tablet with a meal.

How Prichek-M 1 Tablet SR works:

Prichek-M SR, a single-dose tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Prichek-M 1 Tablet SR and alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Prichek-M 1 Tablet SR during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Prichek-M 1 Tablet SR are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Prichek-M 1 Tablet SR cautiously, potentially requiring a modified dosage. Severe kidney disease contraindicates Prichek-M 1 Tablet SR use. Consult a physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Exercise caution when administering Prichek-M 1 Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. A reduced initial dose of Prichek-M 1 Tablet SR is typically prescribed for patients exhibiting mild to moderate liver dysfunction; its use is contraindicated in those with severe liver disease.

What if you forget to take Prichek-M 1 Tablet SR :

Should you forget a dose of Prichek-M 1 Tablet SR, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Prichek-M 1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Prichek-M 1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Prichek-M 1 Tablet SR can cause lactic acidosis, a serious, potentially life-threatening buildup of lactic acid in the blood (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Prichek-M 1 Tablet SR and seek immediate medical attention.
Prichek-M 1 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Prichek-M 1 Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Prichek-M 1 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Prichek-M 1 Tablet SR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Prichek-M 1 Tablet SR and alcohol is unsafe. Alcohol can exacerbate Prichek-M's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Prichek-M 1 Tablet SR
127
MRP 155
18% off